Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial

Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the site's interface. This change represents a software version update rather than changes to the study record content.
    Difference
    0.1%
    Check dated 2026-05-15T06:52:49.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s displayed site revision version was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:42:19.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision 3.5.0 was added to the history. Revision 3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-19T05:24:50.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added and revision v3.4.2 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-12T01:09:17.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The history shows a new revision entry (v3.4.2) indicating an update to the study record; a government funding notice and the prior revision note (v3.4.1) were removed.
    Difference
    0.9%
    Check dated 2026-02-11T11:22:03.000Z thumbnail image

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.